Articles tagged ‘’

Telecare and telehealth systems will be rolled out to the homes of three million people over the next five years as part of a plan to help patients and reduce costs, according to a recent announcement by Prime Minister David Cameron.

Cardiac resynchronisation therapy (CRT) reduces rates of death and re-hospitalisation among heart failure patients according to the European CRT Survey, follow-up results from which were published recently in the European Journal of Heart Failure.¹

New-onset atrial fibrillation (NOAF) following transcatheter aortic valve implantation (TAVI) is associated with higher rates of stroke, and can be independently predicted by larger atrial size and transapical approach, according to a study published recently in the Journal of the American College of Cardiology.¹

Echocardiography has a central role to play in identifying patients at cardiac risk from cancer therapies, and evaluating potential cardioprotective treatments, according to two studies presented recently at the European Society of Echocardiography’s annual ‘EUROECHO and other Imaging Modalities’ 2011 Congress in Budapest, Hungary.

The British Red Cross has launched a free first aid app, advising smartphone users on how to act in an emergency. The app features advice on 18 everyday first aid scenarios, including cases of out-of-hospital cardiac arrest.

Two new clinical reference materials for digoxin have been developed by LGC, the UK’s National Measurement Institute for chemical and bioanalytical measurement.

Men aged 70 and older can elude the Grim Reaper by walking at speeds of at least 3 miles (or 5 km) an hour, according to a study published recently in the Christmas issue of bmj.com.

Newspapers tend to over-report cardiopulmonary resuscitation (CPR) success stories, resulting in a skewed public perception of survival and neurological outcome after cardiac arrest, according to research published recently in the Journal of the Royal Society of Medicine (JRSM).¹

We are delighted to welcome a new sponsor to Arrhythmia Watch. In April 2007 Pfizer and Bristol-Myers Squibb formed an alliance to combine expertise, knowledge and resources to expand treatment possibilities. “Both have a long history of commitment in supporting the management of cardiovascular disease and are proud to extend this support to Arrhythmia Watch,” said a spokesperson.

The number one medical specialty to appear on the New Year’s Honours list in the last decade is public health medicine, according to research published recently in the Journal of the Royal Society of Medicine.¹ However, like other doctors, they will have to work for over 30 years before being recognised.